Filing Details

Accession Number:
0000886163-12-000051
Form Type:
4
Zero Holdings:
No
Publication Time:
2012-09-10 13:55:47
Reporting Period:
2012-09-07
Filing Date:
2012-09-10
Accepted Time:
2012-09-10 13:55:47
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
886163 Ligand Pharmaceuticals Inc LGND Pharmaceutical Preparations (2834) 770160744
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1392266 S Charles Berkman 11119 North Torrey Pines Road, Suite 200
La Jolla CA 92037
Vp, Gen. Counsel & Secretary No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2012-09-07 4,249 $18.77 14,329 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. The Price listed is the average price per share within a sell range of $18.75-$18.81. Upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided.